Cases & Deals

  • Home
  • Practices
  • Bayer HealthCare obtains FTC clearance for acquisition of Teva Animal Health

Share

Bayer HealthCare obtains FTC clearance for acquisition of Teva Animal Health

January 2013

Client(s) Bayer HealthCare LLC

A Jones Day antitrust team secured clearance from the Federal Trade Commission (FTC) on behalf of Bayer HealthCare LLC in its acquisition of Teva Animal Health (TAH) for $60 million plus milestone payments (up to $85 million). The portfolio of Bayer HealthCare's Animal Health division (BAH) includes branded pharmaceuticals for companion animals and livestock. TAH, a division of Teva Pharmaceutical Industries Ltd., sells generic animal health products in the United States.

The transaction provides new channels for BAH's products and adds new products BAH's portfolio. The transaction received FTC clearance on December 31, 2012 and closed on January 3, 2013.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.